Summary Report

Limited Market Approval ✝

SRA or WHO PQ Approval ✝ ✝

Discovery (Target ID / Validation)

Early Development (Lead Optimization, Preclinical, Phase I)

Late Development (Phase 2, Phase 3)

Post-development (Regulatory, Marketed)

Discovery (Target ID / Validation)

Early Development (Lead Optimization, Preclinical, Phase I)

Late Development (Phase 2, Phase 3)

Post-development (Regulatory, Marketed)

Discovery (Target ID / Validation)

Early Development (Lead Optimization, Preclinical, Phase I)

Late Development (Phase 2, Phase 3)

Post-development (Regulatory, Marketed)